Rationale and recommendations for improving early-stage oncology diagnosis, treatment, and access.
Saved in:
| Title: | Rationale and recommendations for improving early-stage oncology diagnosis, treatment, and access. |
|---|---|
| Authors: | Aguiar-Ibáñez R; Merck Canada Inc, Kirkland, QC, Canada., Goldschmidt D; Analysis Group, Inc, Boston, MA, USA., Zhou ZY; Analysis Group Inc, London, UK., Eales J; Analysis Group Inc, London, UK., Peters S; Centre Hospitalier Universitaire Vaudois (CHUV) Oncology Department, Lausanne, Switzerland., Cardoso F; ABC Global Alliance, Lisbon, Portugal., Ciani O; Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Milan, Italy., Arunachalam A, Haiderali A; Merck & Co., Inc., Rahway, NJ, USA., Roediger A; Merck & Co., Inc., Rahway, NJ, USA., Black CM; Merck & Co., Inc., Rahway, NJ, USA., Martinez E; Merck & Co., Inc., Rahway, NJ, USA., Garrison LP Jr; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA. |
| Source: | Journal of medical economics [J Med Econ] 2026 Dec; Vol. 29 (1), pp. 345-362. Date of Electronic Publication: 2026 Feb 07. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
